Therapeutic Advances in Neurological Disorders

eISSN: 1756-2864pISSN: 1756-2856
JournalOpen Access

Journal formatting to fit the target journal guidelines

Experts ensure all elements of your paper match journal formatting guidelines to improve publication success rate!

Key Metrics

CiteScore
9.4
Impact Factor
5 - 10
SJR
Q1Neurology
SNIP
1.87
4
Time to Publish
time-to-publish View Chart
6  Mo

Journal Specifications

Indexed in the following public directories

  • Web of Science Web of Science
  • Scopus Scopus
  • DOAJ DOAJ
  • SJR SJR
Overview
  • Publisher
    SAGE PUBLICATIONS LTD
  • Language
    English
  • Frequency
    Continuous publication
  • Article Processing Charges
    USD 2300
  • Publication Time
    15
  • Editorial Review Process
    Anonymous peer review
General Details
Publication Details
Editorial Review Detail
Information for authors
View less

Ready to spotlight your research findings?

Impress peers and journals alike with a concise, visual summary of your work.

Meets Top Publisher Standards: Essential for leading journals like Elsevier.
Enhances Engagement: Research papers with graphical abstracts receive 3X more downloads and 8X more shares.
Tailored Just for You: We’ll create a custom graphical abstract based on your manuscript—no sketches needed.
Learn more 3000+ graphical abstracts produced with 4.8/5 customer rating
Time to Publish
Time to publish distribution
Articles published in year 2022
Time to publish index
Months% Papers published
0-3 6%
4-6 49%
7-9 31%
>9 14%

Topics Covered

Cladribine
Multiple sclerosis
Parkinson's disease
Ischemic stroke
Alemtuzumab
Patient satisfaction
Breast milk
Cerebrospinal fluid
Placebo
Progressive multifocal leukoencephalopathy
Magnetic resonance imaging
Acute ischemic stroke
Confidence interval
Safety profile
Quality of life
Peginterferon beta-1a
Myopathy
Dimethyl fumarate
Natalizumab
Rituximab

Recently Published Papers

Year-wise Publication

FAQs

Since when has Therapeutic Advances in Neurological Disorders been publishing? Faqs

The Therapeutic Advances in Neurological Disorders has been publishing since 2008 till date.

How frequently is the Therapeutic Advances in Neurological Disorders published? Faqs

Therapeutic Advances in Neurological Disorders is published Continuous publication.

Who is the publisher of Therapeutic Advances in Neurological Disorders? Faqs

The publisher of Therapeutic Advances in Neurological Disorders is SAGE PUBLICATIONS LTD.

How can I view the journal metrics of Therapeutic Advances in Neurological Disorders on editage? Faqs

For the Therapeutic Advances in Neurological Disorders metrics, please refer to the section above on the page.

What is the eISSN and pISSN number of Therapeutic Advances in Neurological Disorders? Faqs

The eISSN number is 1756-2864 and pISSN number is 1756-2856 for Therapeutic Advances in Neurological Disorders.

What is the focus of this journal? Faqs

The journal covers a wide range of topics inlcuding Cladribine, Multiple sclerosis, Parkinson's disease, Ischemic stroke, Alemtuzumab, Patient satisfaction, Breast milk, Cerebrospinal fluid, Placebo, Progressive multifocal leukoencephalopathy, Magnetic resonance imaging, Acute ischemic stroke, Confidence interval, Safety profile, Quality of life, Peginterferon beta-1a, Myopathy, Dimethyl fumarate, Natalizumab, Rituximab.

Why is it important to find the right journal for my research? Faqs

Choosing the right journal ensures that your research reaches the most relevant audience, thereby maximizing its scholarly impact and contribution to the field.

Can the choice of journal affect my academic career? Faqs

Absolutely. Publishing in reputable journals can enhance your academic profile, making you more competitive for grants, tenure, and other professional opportunities.

Is it advisable to target high-impact journals only? Faqs

While high-impact journals offer greater visibility, they are often highly competitive. It's essential to balance the journal's impact factor with the likelihood of your work being accepted.